Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment - 19/06/20
Doi : 10.1016/j.jaad.2020.04.136
Maria Vastarella, MD a, Angela Patrì, MD a, ⁎ 
, Maria Carmela Annunziata, MD a, Mariateresa Cantelli, MD a, Paola Nappa, MD a, Marco Tasso, MD b, Luisa Costa, PhD b, Francesco Caso, PhD b, Gabriella Fabbrocini, MD a
, Maria Carmela Annunziata, MD a, Mariateresa Cantelli, MD a, Paola Nappa, MD a, Marco Tasso, MD b, Luisa Costa, PhD b, Francesco Caso, PhD b, Gabriella Fabbrocini, MD a a Sections of Dermatology and Venereology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy
b Section of Rheumatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Napoli, Italy
∗Correspondence to: Angela Patrì, MD, Department of Clinical Medicine and Surgery, Section of Dermatology and Venereology, University of Naples Federico II, Via Pansini 5, 80131 Naples, ItalyDepartment of Clinical Medicine and SurgerySection of Dermatology and VenereologyUniversity of Naples Federico IIVia Pansini 5Naples80131Italy
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
|
| IRB approval status: Not applicable. |
|
| Reprints not available from the authors. |
© 2020
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 83 - N° 1
P. e77-e79 - juillet 2020 Retour au numéro
Article précédent
- Response to: “Risks of hydroxychloroquine use for COVID-19 prophylaxis”
- Jane M. Grant-Kels
- Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic
- Monica Shah, Haley B. Naik, Raed Alhusayen
Bienvenue sur EM-consulte, la référence des professionnels de santé.